Le Lézard
Classified in: Covid-19 virus

INVESTIGATION REMINDER: The Schall Law Firm Encourages Investors in GSK plc with Losses of $100,000 to Contact the Firm


LOS ANGELES, CA / ACCESSWIRE / August 16, 2022 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of GSK plc ("GSK" or "the Company") (NYSE:GSK) for violations of the securities laws.

https://storage.googleapis.com/accesswire/logos/3060.png

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. GSK's development partner for the proposed COVID-19 treatment sotrovimab, Vir Biotechnology, Inc. ("Vir"), issued a press release on August 9, 2022, stating that the two companies "do not plan to file a Biologics License Application for sotrovimab at this time and do not intend to pursue the US-based Phase 3 COMET-STAR prophylaxis trial. Discussions with the FDA remain ongoing regarding the appropriate path forward for sotrovimab in the US." Based on this news, GSK's American Depositary Receipt price fell by more than 4.3% on August 10, 2022.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at [email protected].

The class in this case has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
[email protected]

SOURCE: The Schall Law Firm



View source version on accesswire.com:
https://www.accesswire.com/712066/INVESTIGATION-REMINDER-The-Schall-Law-Firm-Encourages-Investors-in-GSK-plc-with-Losses-of-100000-to-Contact-the-Firm


These press releases may also interest you

30 sep 2022
The global baby travel bags market is fragmented due to the presence of several established vendors offering a wide range of products. The vendors in the market are incorporating automation in the manufacturing process. They are differentiating...

30 sep 2022
According to the report "Hemp-based Foods Market by Product and Geography - Forecast and Analysis 2022-2026", the market will witness a YOY growth of 10.6% in 2022 and a CAGR of 11.55% during the forecast period. The market has been segmented by...

30 sep 2022
Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until October 11, 2022 to file lead plaintiff applications in a securities class action lawsuit against...

30 sep 2022
The "Humanoid Robot Market by Component and Geography - Forecast and Analysis 2022-2026" report has been added to Technavio's offerings. The humanoid robot market is estimated to grow by USD 9.74 billion from 2021 to 2026. In addition, the growth...

30 sep 2022
The "Automatic Doors Market by Geography (Middle East and Africa, Europe, North America, APAC, and South America) and Product (sliding doors, swing doors, folding doors, revolving doors, and others) - Forecast and Analysis 2022-2026" report has been...

30 sep 2022
The global online sex toys market will be driven by the growing LGBT population in developed countries. The LGBT community is supported by mainstream news media in many developed countries. In 2015, 379 corporations and employer organizations urged...



News published on 16 august 2022 at 13:00 and distributed by: